deltatrials
Completed NA INTERVENTIONAL 1-arm NCT03110861

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

A Prospective, Multicenter, Single Arm Study to Evaluate the Safety and Effectiveness of Implantation of 'Transcatheter Pulmonary Valve (TPV)' for the Treatment of Congenital Heart Disease With Pulmonary Valve Disease

Sponsor: Taewoong Medical Co., Ltd.

Conditions Congenital Heart Defect Pulmonary Valve Stenosis Pulmonary Valve; Insufficiency, Congenital
Interventions Pulsta® Transcatheter Pulmonary Valve (TPV) Replacement
Updated 18 times since 2017 Last updated: Sep 2, 2025 Started: Mar 22, 2017 Primary completion: Nov 6, 2019 Completion: Jul 12, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03110861, this NA trial focuses on Congenital Heart Defect and Pulmonary Valve Stenosis and remains completed. Sponsored by Taewoong Medical Co., Ltd., it has been updated 18 times since 2017, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~May 2017 – ~Oct 2018 · 17 months · monthly snapshot~Oct 2018 – ~May 2019 · 7 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Oct 2019 · 3 months · monthly snapshot~Oct 2019 – ~Apr 2020 · 6 months · monthly snapshot~Apr 2020 – ~Sep 2020 · 5 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jan 2022 · 4 months · monthly snapshot~Jan 2022 – ~Feb 2023 · 13 months · monthly snapshot~Feb 2023 – ~Sep 2023 · 7 months · monthly snapshot~Sep 2023 – ~Apr 2024 · 7 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Sep 2025 · 11 months · monthly snapshot~Sep 2025 – ~Oct 2025 · 30 days · monthly snapshot~Oct 2025 – present · 11 months · monthly snapshot

Change History

18 versions recorded

  1. Oct 2025 — Present [monthly]

    Completed NA

  2. Sep 2025 — Oct 2025 [monthly]

    Completed NA

  3. Oct 2024 — Sep 2025 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  4. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting NA

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

▶ Show 13 earlier versions

  1. Apr 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

  2. Sep 2023 — Apr 2024 [monthly]

    Active Not Recruiting NA

  3. Feb 2023 — Sep 2023 [monthly]

    Active Not Recruiting NA

  4. Jan 2022 — Feb 2023 [monthly]

    Active Not Recruiting NA

  5. Sep 2021 — Jan 2022 [monthly]

    Active Not Recruiting NA

  6. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting NA

  7. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  8. Apr 2020 — Sep 2020 [monthly]

    Active Not Recruiting NA

  9. Oct 2019 — Apr 2020 [monthly]

    Active Not Recruiting NA

  10. Jul 2019 — Oct 2019 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  11. May 2019 — Jul 2019 [monthly]

    Recruiting NA

  12. Oct 2018 — May 2019 [monthly]

    Recruiting NA

  13. May 2017 — Oct 2018 [monthly]

    Recruiting NA

    First recorded

Mar 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Taewoong Medical Co., Ltd.
Data source: Taewoong Medical Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations